Hepatitis B Vaccine Comprehensive patent search

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Usana Health Sciences, Inc.

Usana Health Sciences, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 55 pages

A textual analysis of the financial results for Usana Health Sciences, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Drug and Medication

Salix Pharmaceuticals, Ltd., Wright Investors' Service

Salix Pharmaceuticals, Ltd., Wright Investors' Service

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 56 pages

A textual analysis of the financial results for Salix Pharmaceuticals, Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Drug and Medication

Eurocine Vaccines AB

Eurocine Vaccines AB

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 54 pages

A textual analysis of the financial results for Eurocine Vaccines AB compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication

Ginger Oil AB

Ginger Oil AB

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 55 pages

A textual analysis of the financial results for Ginger Oil AB compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2014
  • 133 pages

BMI View: We commend initiatives launched by Singapore's government to ease the financial burden of healthcare on lower-income patients. However, the limited number of hospital beds and disproportionately high private healthcare expenditure will continue to put pressure on patients. BMI believes Singapore's ...

Industries: Drug and Medication | Countries: Singapore

Argentina Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Argentina Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2014
  • 135 pages

Argentina joined the wide swathe of Latin American countries reporting very solid Q110 real Gross Domestic Product growth figures, with the economy grow ing 6.8% year-on-year (y-o-y) according to official data. This marks the fastest expansion since the final months of the pre-crisis boom in Q308, and ...

Industries: Drug and Medication | Countries: Argentina

Cancer Drug News 24 NOVEMBER 2014

Cancer Drug News 24 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 12 pages

Industry Trend Analysis - BMS/Merck Battle For Melanoma Market Share Industry Brief - Revlimid Gains Swissmedic Approval For r/r MCL Industry Brief - Teva Launches Liquid Formulation Of Treanda Injection In US Industry Brief - BerGenBio's BGB324 Gains FDA ODD For AML Industry Trend Analysis - GSK Collaboration ...

Industries: Drug and Medication | Countries: United States

Sharon Bio-Medicine Ltd

Sharon Bio-Medicine Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 54 pages

A textual analysis of the financial results for Sharon Bio-Medicine Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication

Camphor & Allied Products Ltd

Camphor & Allied Products Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 54 pages

A textual analysis of the financial results for Camphor & Allied Products Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Drug and Medication | Countries: India

Mangalam Drugs & Organics Limited

Mangalam Drugs & Organics Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 55 pages

A textual analysis of the financial results for Mangalam Drugs & Organics Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Drug and Medication

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.